- NSE
- EVONILE
- BSE
- 500672
- ISIN
- INE234A01025
EVONILE PHARMA
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹1,865.20
+₹106.80 (+6.07%)
NSE close ·
EVONILE PHARMA closed at ₹1,865.20 on 9 Nov 2026, up 6.07% on the day, and is up 124.34% over the past year.
Price history
Between 10 Nov 2025 and 9 Nov 2026, the closing price ranged from ₹759.30 to ₹2,428.20.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹4,605 Cr
- Industry P/E
- 35.5
- Dividend yield
- 0.00%
Market cap and yield at the 9 Nov 2026 close. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Jun 2026 | ₹113 Cr | ₹32.21 Cr | — | ₹13.05 |
Armor risk check
EVONILE PHARMA moves about 4× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is EVONILE PHARMA's share price today?
EVONILE PHARMA (NSE: EVONILE) closed at ₹1,865.20 on 9 Nov 2026, up 6.07% from the previous close of ₹1,758.40. It traded between ₹1,800.00 and ₹1,919.00 that day.
What are EVONILE PHARMA's 52-week high and low?
Over the last 52 weeks EVONILE PHARMA traded between ₹750.00 and ₹2,588.80, adjusted for splits and bonuses.
What are EVONILE PHARMA's NSE symbol, BSE code and ISIN?
EVONILE PHARMA has NSE symbol EVONILE, BSE code 500672, ISIN INE234A01025.
How has EVONILE PHARMA performed over 1, 3 and 5 years?
EVONILE PHARMA's share price return: 1Y +124.34%, 3Y +41.65% a year, 5Y +18.30% a year. Dividends are not included.
Does EVONILE PHARMA pay a dividend?
Yes. EVONILE PHARMA's latest dividend went ex on 23 Jul 2025: Final · ₹25.00 per share.
What is EVONILE PHARMA's market cap?
EVONILE PHARMA's market cap is ₹4,605 Cr at the close on 9 Nov 2026.
Which sector is EVONILE PHARMA in?
EVONILE PHARMA is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how EVONILE PHARMA fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app